Mr. Speaker, the member suggests that he supports the TRIPS waiver on patent protection for COVID-related products. This is something that I know many members of the House, from all parties, agree on. Could he perhaps speak a bit more to that issue and its importance?
In the House of Commons on February 10th, 2022. See this statement in context.